Argatroban Antithrombin Anticoagulant
E-mail to a ColleagueArgatroban Site Map
Search Argatroban
Argatroban Home

About Argatroban
Argatroban Clinical Efficacy
Argatroban Safety Profile
Mechanism of Action for Argatroban
Argatroban Dosage & Administration
Argatroban Dosing Calculator
Argatroban Conversion to Oral Anticoagulant Therapy
How is Argatroban Supplied
Argatroban FAQs
Argatroban Emergency Availability
About Heparin-Induced Thrombocytopenia (HIT)

Argatroban & HIT Case Studies

Abstracts, News & Events About Argatroban

Argatroban Materials, Tools & Resources

CME Web Sites

Important Safety Information About Argatroban

Dosing & Indications About Argatroban

Argatroban Dosing Calculator

Pharmacy Case Presentation
Argatroban Injection is supplied in 2.5-mL solution in single-use vials at the concentration of 100 mg/mL. Each vial contains 250 mg of Argatroban.[2]
NDC 0007-4407-01 (Package of 1)

Stability/compatibility

Argatroban is a clear, colorless to pale yellow, slightly viscous solution.[2] If the solution is cloudy or if an insoluble precipitate is noted, the vial should be discarded.

Solutions prepared as recommended are stable at 25°C (77°F) (permitted range: 15°C to 30°C [59°F to 86°F]) in ambient indoor light for 24 hours; therefore, light-resistant measures such as foil protection for intravenous lines are unnecessary.[2]

Solutions are physically and chemically stable for up to 96 hours when protected from light and stored at controlled room temperature, 20°C to 25°C (68°F to 77°F) (see USP), or at refrigerated conditions, 5°C ± 3°C (41°F ± 5°F).

Prepared solutions should not be exposed to direct sunlight.

No significant potency losses have been noted following simulated delivery of the solution through intravenous tubing.